Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Allos Therapeutics to Report First Quarter 2009 Results on May 2009
Allos Therapeutics, 04/29/09
Allos Therapeutics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, announced that Company management will provide a corporate update and review of the first quarter 2009 results via webcast and conference call on Tuesday, May 2009.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09
Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09
Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09
Article Search
Sponsor